Latest

antidepressants

·February 16, 2024·3 min read

Antidepressants Impact Brain Development

Using antidepressants during pregnancy, specifically fluoxetine (found in Prozac and Sarafem), can significantly affect a child's brain development, particularly in the prefrontal cortex, potentially increasing the risk of mental health disorders later in life. The research highlights how serotonin, boosted by fluoxetine, directly impacts the development of synaptic connections in the prefrontal cortex, a critical area for high-order cognitive functions.

Featured Neuroscience Psychology

·February 7, 2024·3 min read

AI Predicts Antidepressant Success in a Week

Researchers developed an AI algorithm that, by analyzing brain scans and clinical information, can predict within a week whether an antidepressant will work for patients with major depression disorder. This method could potentially avoid unnecessary prescriptions of sertraline, a commonly used antidepressant, by identifying non-responders early, thus offering better patient care and reducing side effects.

Featured Neuroscience Psychology

·January 16, 2024·6 min read

Emotional and Social Toll of Antidepressant Withdrawal

New research reveals that coming off antidepressants like Prozac can cause not only physical symptoms but also emotional, cognitive, and social difficulties. The study involved in-depth interviews with 20 individuals who attempted to withdraw from SSRIs in the past year, highlighting the complex challenges they faced, including emotional overwhelm, reduced enjoyment in social situations, and a feeling of detachment.

Featured Neuroscience Psychology

·October 19, 2023·6 min read

Does Drug Effect or Power of Belief Explain Ketamine’s Antidepressant Effect?

Researchers conducted a unique study to uncover the efficacy of ketamine in treating depression, bypassing its unmistakable psychedelic effects by administering it during surgery. Surprisingly, both the ketamine and placebo groups showed substantial improvement in depression symptoms.

Featured Neuroscience Psychology

·October 7, 2023·6 min read

Running Parallels Antidepressants in Reducing Depression

Researchers offered 141 patients with anxiety and/or depression a choice between 16 weeks of SSRIs (antidepressants) or group running therapy, revealing both options approximately equally benefited mental health. However, physical health improvements—including weight, waist circumference, and cardiovascular function—were notably observed in the running group, despite a higher dropout rate.

Featured Neuroscience Psychology

·September 13, 2023·4 min read

Antidepressants May Boost Memory Function and Reduce Negative Memories

A new study delves into the relationship between antidepressants and memory dynamics. The study reveals that these drugs may dampen negative memories and bolster overall memory function in individuals with depression.

Featured Neuroscience Psychology

·August 29, 2023·6 min read

Treating Mom’s Postnatal Depression with SSRIs Also Boosts Child Behavior

A new study found that treating postnatal depression with selective serotonin reuptake inhibitors (SSRIs) benefits not just mothers but also their children. The study, which analyzed data from over 61,000 mothers and their children, shows that SSRI treatment led to better outcomes up to five years after childbirth.

Featured Neuroscience Psychology

·August 3, 2023·5 min read

GABA Receptors Unveiled as Potential Antidepressant Targets

A new study argues the neurotransmitter GABA and its principal receptors could play a key role in managing depressive disorders. Researchers suggest potential pathways through which GABA-modulating treatments could alleviate both cognitive and affective symptoms linked to depression.

Featured Neuroscience Psychology

·August 3, 2023·6 min read

Extended Antidepressant Therapy Curbs Relapses in Bipolar Disorder

Researchers lead a global clinical trial suggesting that long-term use of modern antidepressants could reduce depressive relapses in patients with bipolar disorder. This challenges current clinical practice guidelines and might significantly change how bipolar depression is treated worldwide.

Featured Neurology Neuroscience Pain

·July 24, 2023·5 min read

Easing Pain, Safely: Antidepressant’s Promise for Neuropathic Pain Relief

Neuropathic pain, impacting an estimated 10% of the global population, could be tackled more safely and effectively with the atypical antidepressant tianeptine. Researchers found that tianeptine offers rapid, long-lasting relief from pain with a lower risk of addiction.

Featured Neuroscience Psychology

·June 24, 2023·8 min read

Cognitive Biotype: A Novel Depression Subcategory Defying Conventional Treatments Identified

Researchers discovered a new depression subtype, the 'cognitive biotype,' affecting 27% of patients who respond poorly to typically prescribed antidepressants. These patients struggle with planning, self-control, sustained focus, and suppressing inappropriate behavior, with brain scans revealing reduced activity in the regions responsible for these tasks.

Featured Neuroscience Psychology

·June 14, 2023·6 min read

Probiotics Enhance Antidepressant Efficacy for Major Depressive Disorder

A probiotic blend comprising 14 strains of bacteria can enhance the treatment of major depressive disorder when used alongside antidepressants. This pilot study highlights the potential of probiotics in promoting improvements in mood over an eight-week period. It is a pioneering exploration into how gut health, improved via probiotics, could pave the way for a novel approach to bolster mood and mental health.